
2024-01-24T07:04:22
First-trimester screening is a set of prenatal tests conducted during the first trimester of pregnancy to assess the risk of certain chromosomal abnormalities, particularly Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). This screening typically involves a combination of ultrasound measurements and blood tests: Nuchal Translucency (NT) Scan: This ultrasound test measures the thickness of the nuchal fold at the back of the baby's neck. An increased thickness may indicate a higher risk of certain chromosomal abnormalities. Blood Tests: These tests include the measurement of specific hormones in the mother's blood, such as pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotropin (hCG). Deviations from normal levels may suggest an increased risk of chromosomal abnormalities. The results of these tests, when combined, help estimate the likelihood of the fetus having a chromosomal abnormality. It's important to note that these are screening tests, not diagnostic tests. If the screening indicates an increased risk, further diagnostic tests such as chorionic villus sampling (CVS) or amniocentesis may be recommended to confirm the diagnosis. To know more consult our Best Gynecologist Dr Swati Khandekar at her Aasavari Clinic Malviya Nagar Khamla Nagpur. #NTScans #gynecologistnearme #bestgynecologistnearme #topgynecologistnearme #no1gynecologistnearme #top10gynecologistnearme